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We discuss two threshold phenomena in blood coagulation dynamics using a simplified model.
This perspective of the underlying complex phenomena is expected to aid the understanding and
characterization of many blood coagulation pathologies with altered protein dynamics.
I. THE UNUSUAL SUSPECTS
It is usual to think of nonlinear dynamics while mod-
eling problems with the heart [8] and the brain [7] cells.
Some known hematological disorders that are of dynam-
ical nature are centered around blood cells [14].
In this letter, we try to bring to light many more dy-
namical problems with blood coagulation that are cen-
tered around proteins and, in particular, an usual sus-
pect named thrombin. We do this by using a simplified
dynamical model for an important part of the blood co-
agulation cascade concerning thrombin. We focus on two
of its essential threshold behavior.
II. COMPLEXITY AND CLUTTER
Many pathologies of blood coagulation are under-
stood in terms of altered states of blood chemistry [17].
Decades of experimental work studying chemical kinetics
have led to models for atomic parts of the system built
using individual reactions. Such models describing ki-
netics using M reactions are usually concatenated to the
form [11],
d[Yi]
dt
=
M∑
j=1
Sijrj([Y];kj), (1)
s.t. [Yi](0) = [Yi]
0,
S[Y] = S[Y]0,
[Yi] ≥ 0,
where Sij are stoichiometric coefficients (with i =
1, ..., N, j = 1, ...,M), rj are reaction rates, kj are
parameters of the reaction rates, and [Yi]
0 are the ini-
tial plasma composition. However, pathologies involving
alterations in dynamics of the blood chemical reactions
have not been well understood.
Concentration of proteins involved in coagulation and
rates of reactions vary by orders of magnitude. Essen-
tially, picomoles of trigger results in the formation of hun-
dreds of nanomoles of certain enzymes. This in turn re-
sults in macroscopic formation of polymeric-fibrous clots.
The system has so far been impenetrable towards under-
standing the of the sum of the parts. Partly, this could
reasoned based on Figure 1. Eigenvalues (plotted in log
scale) of the Jacobian of the reaction rates of clotting
obtained from a specific model [11] portrays a ghastly
serpentine picture.
FIG. 1. Eigenvalues of the Jacobian of reaction rates as a
function of time. The model, which describes dynamics of
34 proteins using 42 reactions, is very stiff and the solution
trajectories are unstable in many directions. The zero eigen-
values are due to 9 stoichiometric constraints. Only 5 out of
the 9 constraints are met due to numerical precision.
Geometrical analysis of chemical kinetic systems such
as in combustion show such complexity [18]. Possible co-
existence of qualitatively different local instabilities along
a trajectory in such multi-dimensional systems [16] ob-
fuscate the process. Needless to say, the formidability of
formulating meaningful hypothesis and designing good
experiments have lead to ambiguous theories [9], exper-
imental data that is often hard to interpret, and some-
times even compromised [13]. Nevertheless, artful analy-
sis of such models have affirmed them to be useful think-
ing tools [15] and certain aspects of the dynamics show
sustained promise in a clinical setting [6].
Recently, there have been attempts to use black box
machine learning tools to practically apply the system
[3]. But the urge to understand the nature of things
have further led to a simplified model for the essential
dynamics [2] (also [4]). Here we attempt to draw it.
2III. SIMPLIFICATION AND STRUCTURE
We consider the essential dynamics of concentration
just four species: i) bursting enzyme thrombin [IIa], ii)
precursor prothrombin [II], iii) inhibitor antithrombin
III [ATIII], and iv) by-product thrombin-antithrombin
[IIa-ATIII].
A. Simplified Model
The simplified model is given by,
d
dt
[II] = −KS −KP [II][IIa]
d
dt
[IIa] = KS +KP [II][IIa]−KI [IIa][ATIII]
d
dt
[AT] = −KI [IIa][ATIII]
The rate of change of the by-product is given by
d
dt
[IIa-ATIII] = KI [IIa][ATIII] so that stoichiometry is
preserved. The ‘macroscopic’ model phenomenologically
accounts for the effect of myriads of other ‘microscopic’
species in the rate parameters. Further, this drastic sim-
plification deals with the intrinsic complexity by means
of switching, i.e., the rate parameters abruptly switch
based on the amount of enzyme [IIa] present (Table I).
Moreover, the switching was designed to reflect the two
threshold phenomena discussed next.
TABLE I. Switching Condition. Estimates for the physiolog-
ical mean plasma are ks = 0.005 nMs
−1 (for 5 pM of trigger),
ki2 = 1.9551E − 07 nM
−1s−1, ki1 = 6.347E − 06 nM
−1s−1,
and kp = 4.155E − 05 nM
−1s−1.
[IIa] < 2 nM [IIa] ≥ 2 nM
KS ks > 0 0
KI ki2 > 0 ki1 > 0
KP 0 kp > 0
There are essentially two threshold phenomena exhib-
ited by the simplified model: i) all-or-none clot initiation
and ii) sustained clot propagation. To avoid false trig-
gers, clot initiates only if there are sufficient amounts of
initiation triggers present; clot better not initiate due to
weak triggers. Further, clotting better be put in check.
There are, normally, more than enough inhibitors in the
blood to do so. In certain abnormal cases when they are
inadequate, the model predicts that clotting need not ter-
minate. The two thresholds arise from the two necessary
functional roles. The former concerns with hypocoagula-
tion while the latter is a signature of hypercoagulation.
We describe these behavior primarily using 2D projec-
tions of the phase portrait of the simplified model. In
addition, we use log scales, as and when needed, in order
to tame aspects of the ghastly serpent. To aid interpre-
tation of the figures, we note that thrombin, i.e., IIa, is
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FIG. 2. Typical response of the model variables during
clotting for the physiological mean: [ATIII]0 = 3400 nM,
[II]0 = 1400 nM, [IIa]0 = [IIa-ATIII]0 = 0.
an enzyme that catalyzes clot formation and its presence
signifies clotting in almost all cases.
B. To Clot or Not to Clot?
Figure 3 shows thrombin generation profiles for varying
values of ki2. [IIa] concentration at t = 800s show a delay
in clot initiation with larger values of ki2. Dependence on
maximum values of [IIa] on ki2 suggest clotting does not
initiate in the time frame for values of ki2 above a certain
threshold. Figure 4 shows the projection of the trajec-
tories on a 2D plane. The zoomed version better shows
the threshold effect of the ki2 on clot initiation. Hypoco-
agulation occur in many well-known forms of hemophilia
when certain proteins are deficient [17].
C. To Terminate or To Propagate?
Figure 5 shows the effect of initial [ATIII]0 on [IIa]
dynamics. Activity of [IIa] sustains for certain values of
initial [ATIII]0. This is seen in value of [IIa] at t = 3600s.
In this model, [IIa] runs out of [ATIII]. Trajectory pro-
jections on a 2D plane in Figure 6 show the marked differ-
ence between normal thrombin trajectory and sustained
activity. This fact, observed in experimental model sys-
tems [1], could have escaped most experimentalists if they
had measured [IIa-ATIII] to infer [IIa] or used a very
common method that was recently found to be compro-
mised [13] (and explainable due to sustained [IIa] activ-
ity).
ATIII is deficient in many hypercoagulative patholo-
gies [19]. This model predicts [ATIII]0/[II]0 ≥ 1 (for
[II]0 = 1400 nM, [ATIII]0 = 1400 nM or 41% of physio-
logical mean [11]) to avoid hypercoagulation. Reported
data on hypercoagulative disseminated intravascular co-
agulation (DIC) patients has a mean of 66% [ATIII]0
[5]. This corroboration is hindered due to the fact that
[II]0 values are not reported together with [ATIII]0 (very
3FIG. 3. Simplified all-or-none clot initiation. Data from a
specific parameter value is highlighted in red.
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FIG. 4. 2D projections of reaction trajectories depicting
thrombin initiation.
likely, the significance of the ratio is first highlighted by
this study). Further, many ATIII assays measure rela-
tive percent of ATIII and there are two different reported
physiological mean values [11, 12] (the other value is 2500
nM).
ATIII deficiency could be due to faulty synthesis, in-
creased consumption, loss (such as filtration in kidneys),
etc. [19]. The proteins not explicitly accounted for in
this model would precisely determine the threshold value
FIG. 5. Simplified threshold response of clot propagation
based on antithrombin (and prothrombin ratio).
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FIG. 6. 2D projections of reaction trajectories due to An-
tithrombin III variation.
of the ratio. Models accounting for other inhibitors like
activated protein C could better explain the nature of
stability in the different regions of the phase portrait.
IV. EXCITEMENT AND ENTHUSIASM
The three physiologically different simulation re-
sponses including the two threshold responses are sum-
marized in Figure 7. In the simplified model response,
there is no clot initiation in hypocoagulation, and there is
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FIG. 7. Summary of threshold phenomena in the simplified
model.
sustained [IIa] activity in hypercoagulation. The extent
to which ‘normal’ trajectories remain normal demands
judicious experimental studies. For example, circulation
could amplify seemingly minor differences in clotting at
a particular location due to the effect of time delay.
Circulation along with diffusion also introduce a spa-
tial aspect to the reaction trajectories. Another key
contribution of this simplified analysis is that it offers
an explanation for the effect of clotting in one part of
the body on clotting elsewhere using sustained throm-
bin activity. Such activity could potentially propagate
downstream leading to dire consequences as in the case
of DIC [20]. Further, understanding and modeling the
feedback mechanisms and drug administration that con-
trol the amount of proteins in the blood such as II and
ATIII, and the reaction dynamics [10], opens up a way to
understand the possibly dynamical [14] nature of many
blood coagulation pathologies.
Promisingly, as the perspective suggests, measure-
ments made somewhere in the body could reveal a lot
on what is likely to happen at many other places.
V. INTRODUCTION
We offered a simplified depiction of the blood coagu-
lation cascade and emphasized three essentially different
physiological responses. We hope this paper brings to
light, to the nonlinear dynamics community, the simi-
lar nature of blood coagulation disorders associated with
proteins and, in the process, eventually catalyzes ad-
vances in better diagnosis and treatment. Though the
simplified picture is far from reality, it would be wronger
than wrong to dismiss its implications. We also expect
that the serpent we have portrayed is only a part of a
larger elephant. Thrombin is multi-functional and plays
an active role in pathways associated with diseases such
as inflammation and cancer.
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